These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 22441722)

  • 21. Effects of hyperprolactinemia treatment with the dopamine agonist quinagolide on endometriotic lesions in patients with endometriosis-associated hyperprolactinemia.
    Gómez R; Abad A; Delgado F; Tamarit S; Simón C; Pellicer A
    Fertil Steril; 2011 Mar; 95(3):882-8.e1. PubMed ID: 21055747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and laboratoristic strategy in late onset hypogonadism.
    Lombardo F; Lupini C; Meola A; Pallotti F; Gandini L; Lenzi A
    Acta Biomed; 2010; 81 Suppl 1():85-8. PubMed ID: 20518196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of hyperprolactinemia and its control on metabolic diseases.
    Auriemma RS; De Alcubierre D; Pirchio R; Pivonello R; Colao A
    Expert Rev Endocrinol Metab; 2018 Mar; 13(2):99-106. PubMed ID: 30058862
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectopic hyperprolactinaemia due to a malignant uterine tumor resembling ovarian sex cord tumors (UTROCST).
    Dimitriadis GK; Wajman DS; Bidmead J; Diaz-Cano SJ; Arshad S; Bakhit M; Lewis D; Aylwin SJB
    Pituitary; 2020 Dec; 23(6):641-647. PubMed ID: 32857272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy: Valvulopathy in patients treated for hyperprolactinemia?
    Droogmans S; Van Camp G
    Nat Rev Endocrinol; 2010 Jul; 6(7):357-8. PubMed ID: 20571535
    [No Abstract]   [Full Text] [Related]  

  • 26. Hyperprolactinaemia.
    Demssie YN; Davis JR
    Clin Med (Lond); 2008 Apr; 8(2):216-9. PubMed ID: 18478876
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversal of hypogonadotropic hypogonadism with tamoxifen in a patient with hyperprolactinemia resistant to dopamine agonists.
    López JM; Oestreicher E
    Fertil Steril; 2005 Sep; 84(3):756. PubMed ID: 16169415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypogonadism secondary to hyperprolactinaemia: successful treatment but adverse consequences.
    Narayanan RP; Bujawansa S; Qureshi Z; Rimmer M; Heald A
    Exp Clin Endocrinol Diabetes; 2012 May; 120(5):311-3. PubMed ID: 22441722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment for prolactinomas and hyperprolactinaemia: a lifetime approach.
    Mann WA
    Eur J Clin Invest; 2011 Mar; 41(3):334-42. PubMed ID: 20955213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antipsychotic-induced hyperprolactinaemia.
    Inder WJ; Castle D
    Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature.
    Sodi R; Fikri R; Diver M; Ranganath L; Vora J
    Ann Clin Biochem; 2005 Mar; 42(Pt 2):153-9. PubMed ID: 15829128
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.